Cargando…
Treating diabetic all-comers with contemporary drug-eluting stents: Prespecified comparisons from the BIO-RESORT and the BIONYX randomized trials
BACKGROUND: Patients with diabetes have more extensive coronary disease, resulting in higher risks of adverse clinical events following stenting. In all-comer patients, contemporary DES have shown excellent safety and efficacy, but data on diabetic patients are scarce. Separately for the BIO-RESORT...
Autores principales: | Ploumen, Eline H., Buiten, Rosaly A., Kok, Marlies M., Doggen, Carine J.M., Roguin, Ariel, Jessurun, Gillian A.J., Schotborgh, Carl E., Danse, Peter W., Benit, Edouard, Aminian, Adel, van Houwelingen, K. Gert, Stoel, Martin G., Scholte, Martijn, Hartmann, Marc, Linssen, Gerard C.M., Zocca, Paolo, von Birgelen, Clemens |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7581320/ https://www.ncbi.nlm.nih.gov/pubmed/33148427 http://dx.doi.org/10.1016/j.ijcard.2020.10.051 |
Ejemplares similares
-
Acute myocardial infarction treated with novel Resolute Onyx and Orsiro stents in the randomized BIONYX trial
por: Ploumen, Eline H., et al.
Publicado: (2021) -
Final 5‐Year Report of the Randomized BIO‐RESORT Trial Comparing 3 Contemporary Drug‐Eluting Stents in All‐Comers
por: Ploumen, Eline H., et al.
Publicado: (2022) -
Three contemporary thin‐strut drug‐eluting stents implanted in severely calcified coronary lesions of participants in a randomized all‐comers trial
por: Buiten, Rosaly A., et al.
Publicado: (2020) -
Three‐year clinical outcome in all‐comers with “silent” diabetes, prediabetes, or normoglycemia, treated with contemporary coronary drug‐eluting stents: From the BIO‐RESORT Silent Diabetes study
por: Ploumen, Eline H., et al.
Publicado: (2019) -
Impact of prediabetes and diabetes on 3-year outcome of patients treated with new-generation drug-eluting stents in two large-scale randomized clinical trials
por: Ploumen, Eline H., et al.
Publicado: (2021)